Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection
2006 ◽
Vol 44
(2)
◽
pp. 275-282
◽
Keyword(s):